Apsis Aerocom Ltd Q4 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/tklapl9xyoci4lvaqnb41cgn.pdf

# 1. Financial Performance

## A. Key Figures
   *   **PAT:** **₹7.5 Cr** FY26 (+13.8%) · **24.51%** Margin

## B. Revenue & Profitability Trends
   *   **Top-line Acceleration:** Delivered robust full-year growth and a significant H2 surge, underpinned by an expanded customer base and enhanced manufacturing infrastructure.
   *   **Margin Compression Drivers:** Profitability margins moderated due to fixed costs associated with the **delayed Unit 2 facility**, elevated raw material costs from geopolitical volatility, and one-time listing expenses.
   *   **Strategic Opex Reinvestment:** Increased employee and operational spending reflects deliberate investments in leadership teams and governance frameworks to support future scalability.
   *   **Debt Avoidance:** Management is intentionally bypassing bank loans of **₹40–50 Cr** to protect margins from high effective interest rates of **11–12%**.

## C. Working Capital & Cash Conversion
   *   **Enhanced Collection Efficiency:** Trade receivables as a percentage of revenue saw a meaningful reduction, supported by a disciplined **45-day** average collection period.
   *   **Operational Cash Strength:** Significant year-on-year growth in cash flow from operations demonstrates a high-quality transition of earnings into liquid capital.
   *   **Inventory Management:** Maintained healthy operational liquidity with an inventory turnover of **77 days**.

## D. Capital Allocation & IPO
   *   **Strategic Equity Raise:** The FY26 SME IPO was utilized to secure growth capital for scaling operations beyond the constraints of the current small-scale facility.
   *   **De-risked Balance Sheet:** Chose equity over debt to fund the significant upfront investments required for the company's next growth phase without the burden of interest obligations.

---

# 2. Manufacturing & Capacity

## A. Key Figures
   *   **Unit 2 Investment:** **₹60 Cr** for machinery and infrastructure
   * Projected Revenue: ₹30 Cr Unit 1 (Full Capacity) · ₹18 Cr Unit 2 (less than 50% Capacity)
   *   **Asset Base:** **₹12 Cr** Net PPE (vs. ₹7 Cr YoY)
   *   **Unit 3 Potential:** **>₹70 Cr** estimated additional business

## B. Unit 2 Expansion
   *   **Strategic Scaling:** Establishing a precision machining facility in Bangalore’s Hitech Aerospace Park to support complex, high-throughput projects.
   *   **Phased Commissioning:** Operations expected to commence in **Q2 FY27** (July/August 2026), with a full machine complement of **35 units** installed by **December** for full-fledged FY28 operations.
   *   **Conservative Utilization:** Revenue targets for the new facility are based on operating at less than half capacity, providing significant headroom for future growth.

## C. Production Infrastructure
   *   **Technological Upgrades:** FY26 focus on digital tools and automation to reduce turnaround times and enhance precision across the manufacturing footprint.
   *   **Capital Deployment:** Significant expansion of the asset base and machinery procurement funded via **IPO proceeds**, slated for full operationality by FY28.

## D. Unit 3 Planning
   *   **Future Diversification:** Identified land for a third facility focused on mechanical assemblies, targeting the aerospace, defense, and healthcare verticals.
   *   **Revenue Multiplier:** While investment is not yet finalized, Unit 3 is positioned to more than double the combined revenue potential of the existing units.

---

# 3. Segment & Product Performance

## A. Key Figures
   *   **Defence Revenue:** **₹20 Cr** (~65% of total)
   *   **Aerospace Revenue:** **₹7.85 Cr** (~26% of total)
   *   **Healthcare Revenue:** **₹2.36 Cr** (~8-10% of total)
   *   **Exclusive Component Mix:** **40%** of total revenue

## B. Segment Dynamics & Outlook
   *   **Defence Dominance:** The segment remains the primary growth engine with the majority of contracts delivered ahead of schedule.
   *   **Aerospace Pipeline:** Robust segment contribution supported by the development of **15 new components** ready for production and a significant project pipeline for FY28-FY29.
   *   **Healthcare Evolution:** Segment poised for scaling with a newly upgraded system scheduled for production in the coming year.

## C. Product Strategy & Competitive Moat
   *   **High-Complexity Focus:** Management maintains consistent profitability by targeting complex precision components requiring advanced machining, intentionally avoiding commoditized products.
   *   **Strategic Exclusivity:** Strong market positioning as the exclusive supplier for critical parts, with nearly half of revenue derived from monopolistic components.
   *   **Competitive Landscape:** Limited domestic competition, with the non-exclusive portfolio facing only **one or two** local rivals.
   *   **Customer Retention:** While prioritizing high-value parts, the company selectively accepts medium-complexity orders to preserve long-term client relationships.

---

# 4. Customer & Market Mix

## A. Key Figures
   *   **Sector Mix:** **₹25 Cr** Defence · **₹12.9 Cr** Aerospace
   *   **Customer Concentration:** **35%** Largest Customer (vs. 52% YoY) · **87%** Top 5 Customers (vs. 94% YoY)

## B. Order Book Dynamics
   *   **Robust Pipeline & Conversion:** Total bookings exceeded **40.5 crore** for the year, supported by a massive **>100 crore** pipeline; conversion remains capped at **30%** due to production capacity constraints.
   *   **Execution Timeline:** Management expects to liquidate the majority of the current backlog within one year, with medium-term defence contracts split between short-cycle (<1.5 years) and mid-cycle (2-2.5 years) durations.
   *   **Strategic Growth:** Current backlog represents significant expansion over the prior year, bolstered by **30 crore** in new orders specifically targeting the FY27 pipeline.

## C. Customer Concentration & Acquisition
   *   **Diversification Progress:** Significant reduction in single-customer dependency following the IPO, which provided the capital necessary to move beyond a historical **3 to 5** major client limit.
   *   **Client Base Expansion:** Successfully onboarded **more than 4** new customers since February 2026, expanding the total base to **15-20** clients while maintaining 12-year relationships with core partners.
   *   **Global-Domestic Hybrid:** While deliveries are primarily domestic for the Indian Air Force and Navy, demand is largely driven by **foreign OEMs** via defense offset obligations and local joint ventures.

## D. Acquisition Strategy
   *   **Ecosystem Benchmarking:** Growth is fueled by **OEM approvals**, which act as a critical quality signal to the broader aerospace market, alongside active participation in industry exhibitions and networks.

---

# 5. Technology & Innovation

## A. Key Figures
   * R&D Investment: 7% to 10% of business spent on R&D
   *   **Product Development:** **250+** new components validated in FY26
   *   **R&D Headcount:** **15 to 20** dedicated personnel

## B. Engineering & R&D Strategy
   *   **Sector Diversification:** R&D efforts are strategically concentrated on high-barrier sectors including healthcare, defense, and aerospace to drive future growth.
   *   **Pipeline Visibility:** Robust component validation activity in the current fiscal has established a significant production runway for FY27.
   *   **Technical Workflow:** The development cycle utilizes advanced computer-based simulations and rigorous process validation before transitioning to sample-part machining.

## C. Intellectual Property & Competitive Moat
   *   **Process Barriers:** Apsis maintains a durable competitive advantage, with peers unable to replicate components for **5 years** due to high individual competency requirements and engineering limitations.
   *   **IP Bifurcation:** The company employs a strategic IP split where customers own the CAD designs, while Apsis retains ownership of the critical CAM (Computer-Aided Manufacturing) processes.

## D. Quality Assurance & Compliance
   *   **Operational Excellence:** High success rates and delivery accuracy are underpinned by specialized process expertise and a lack of major non-conformances in audits.
   *   **Certification Profile:** Management clarified that **NADCAP certification** is currently unnecessary as the company does not perform the specific "special processes" that mandate it.
   *   **Validation Protocols:** Stringent quality standards are maintained through a dual-layer protocol involving both internal testing and customer-side validation.

---

# 6. Risks & External Factors

## A. Supply Chain & Procurement
   *   **Extended Lead Times:** Post-IPO procurement of advanced precision machinery from Europe and Japan faces significant delivery windows of **6 to 10 months**.
   *   **Strategic Sourcing:** Capital deployment is focused on high-end international equipment to support technical scaling, despite the elongated supply chain cycle.

## B. Risk Management & Execution
   *   **Input Cost Mitigation:** Raw material volatility is managed through active global trend monitoring and dynamic pricing adjustments for new order quotes.
   *   **Prioritizing Operational Integrity:** Management is intentionally favoring execution capability over aggressive volume scaling to mitigate operational risks in the Aerospace and Defense sectors.

---

# 7. Guidance & Outlook

## A. Key Figures
   * **Revenue Targets:** **₹48 Cr** FY27 target · **<₹50 Cr** next fiscal year target · **₹90–100 Cr** FY28 run-rate · **₹500 Cr** 2031 goal
   * Target Revenue Mix: 60% Defence · 30% Aerospace · 20% Healthcare/Other
   *   **EBITDA Margin:** **37% to 40%** steady-state projection
   *   **Capacity Potential:** **₹30 Cr** Unit 1 capacity · **₹60 Cr** Unit 2 incremental revenue (FY28)

## B. Revenue Targets & Growth Trajectory
   *   **Near-Term Scaling:** Revenue growth in the coming fiscal year will be anchored by the partial operationalization of the new **Unit 2 facility**, despite a total pipeline exceeding **₹100 crore**.
   *   **Long-Term Ambition:** Management is targeting a significant top-line expansion over the next 3–5 years, driven by a shift toward **complex parts** requiring specialized infrastructure.
   *   **Sector Diversification:** Future revenue is expected to be heavily weighted toward the defense sector, followed by aerospace and healthcare.

## C. Long-term Strategy
   *   **Strategic Evolution:** Transitioning from a precision manufacturer to a strategic partner for global OEMs, focusing on **advanced precision machining** and the **Atmanirbhar Bharat** initiative.
   *   **Operational Pillars:** Growth strategy rests on maximizing capacity, customer diversification, and automation to ensure disciplined capital allocation.
   *   **Extended Visibility:** While firm orders are medium-term, project projections typically span a **5 to 6-year horizon**, with post-FY28 growth fueled by value-added services.

## D. Margin Sustainability
   *   **Profitability Outlook:** Management expects to sustain high double-digit EBITDA margins, supported by operating leverage from Unit 2 and a healthy pipeline.
   *   **Risk Factors:** While margins are deemed stable for the next 3 years, long-term projections (FY30-31) remain sensitive to **currency volatility** and **geopolitical impacts** on raw material costs.

## E. Capacity Projections
   *   **Infrastructure Expansion:** The new Unit 2 facility provides double the footprint of Unit 1, positioning the company to reach its full-capacity revenue run-rate by FY28.